Skip to Main Content

Author Details

Albert J Chang
University of California Los Angeles
2003
61
20
PMIDPaper TitleJournal TitlePublished Year
36723856Multimodality Therapies for Localized Prostate Cancer.Curr Oncol Rep2023
37650773Analytical HDR prostate brachytherapy planning with automatic catheter and isotope selection.Med Phys2023
37647496Selecting the optimal radiation modality in prostate cancer.Clin Adv Hematol Oncol2023
37059334Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study.Radiother Oncol2023
36725382Bladder only versus bladder plus pelvic lymph node chemoradiation for muscle-invasive bladder cancer.Urol Oncol2023
34732290American Brachytherapy Society radiation oncology alternative payment model task force: Quality measures and metrics for brachytherapy.Brachytherapy2022
35847550Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 Trial.Adv Radiat Oncol2022
35350564Rectal Radiation Dose and Clinical Outcomes in Prostate Cancer Patients Treated With Stereotactic Body Radiation Therapy With and Without Hydrogel.Front Oncol2022
35057827Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost.Radiat Oncol2022
35050303Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.JAMA Oncol2022
34866018Trends and Predictors of Hypofractionated and Intensity-Modulated Radiotherapy for Organ Preservation in Bladder Cancer.Clin Genitourin Cancer2022
31411981Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate Cancer.Eur Urol Oncol2021
34670276High-Dose Rate Interstitial Spine Brachytherapy Using an Intraoperative Mobile Computed Tomography-Guided Surgical Navigation System.Oper Neurosurg (Hagerstown)2021
34550749Socioeconomic and Racial Determinants of Brachytherapy Utilization for Cervical Cancer: Concerns for Widening Disparities.JCO Oncol Pract2021
34098977Outcomes with multi-disciplinary management of central lung tumors with CT-guided percutaneous high dose rate brachyablation.Radiat Oncol2021
34097458Payment Methodology for the Radiation Oncology Alternative Payment Model: Implications for Practices and Suggestions for Improvement.JCO Oncol Pract2021
34196715Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.JAMA Netw Open2021
32663537Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients.Radiother Oncol2020
33279016Use of stereotactic body radiotherapy in gynecologic cancers: Local control with systemic treatment implications.Gynecol Oncol2020
33305096Clinical Development and Evaluation of Megavoltage Topogram for Fast Patient Alignment on Helical Tomotherapy.Adv Radiat Oncol2020
30580002Impact of Staging <sup>68</sup>Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate Cancer.Urology2019
30954399Single-fraction brachytherapy as monotherapy for early-stage prostate cancer: The UCSF experience.Brachytherapy2019
31084904The American Brachytherapy Society consensus statement on intraoperative radiation therapy.Brachytherapy2019
29125731Imaging PD-L1 Expression with ImmunoPET.Bioconjug Chem2018
30212298The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee Endorse the American Society of Clinical Oncology/Cancer Care Ontario Guidelines.J Clin Oncol2018
31014789In Reply to Gensheimer and Trister.Int J Radiat Oncol Biol Phys2018
29709315Salvage HDR Brachytherapy: Multiple Hypothesis Testing Versus Machine Learning Analysis.Int J Radiat Oncol Biol Phys2018
29203149Improved rectal dosimetry with the use of SpaceOAR during high-dose-rate brachytherapy.Brachytherapy2018
27513849<sup>18</sup>F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate- to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons.Radiology2017
28274401Receiver operating curves and dose-volume analysis of late toxicity with stereotactic body radiation therapy for prostate cancer.Pract Radiat Oncol2017
28869143A novel urethral sparing technique for high-dose-rate prostate brachytherapy after transurethral resection of the prostate.Brachytherapy2017
28522741Impact of <sup>68</sup>Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer.J Nucl Med2017
28071340Respiration-Induced Intraorgan Deformation of the Liver: Implications for Treatment Planning in Patients Treated With Fiducial Tracking.Technol Cancer Res Treat2017
27199276Interfraction Anatomical Variability Can Lead to Significantly Increased Rectal Dose for Patients Undergoing Stereotactic Body Radiotherapy for Prostate Cancer.Technol Cancer Res Treat2017
27511849Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy.Int J Radiat Oncol Biol Phys2016
25533416Bladder wall recurrence of prostate cancer after high-dose-rate brachytherapy.Brachytherapy2015
26198421Patient- and treatment-specific predictors of genitourinary function after high-dose-rate monotherapy for favorable prostate cancer.Brachytherapy2015
25983194Patterns of Local Failure following Radiation Therapy for Prostate Cancer.J Urol2015
25795252Dose-volume analysis and the temporal nature of toxicity with stereotactic body radiation therapy for prostate cancer.Pract Radiat Oncol2015
24445997Roles of Atox1 and p53 in the trafficking of copper-64 to tumor cell nuclei: implications for cancer therapy.J Biol Inorg Chem2014
25475226Editorial comment.Urology2014
25060207Positron emission tomographic imaging of copper 64- and gallium 68-labeled chelator conjugates of the somatostatin agonist tyr3-octreotate.Mol Imaging2014
24840073High-risk prostate cancer-classification and therapy.Nat Rev Clin Oncol2014
24484652Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir.Radiat Oncol2014
23141886Utility of normal tissue-to-tumor α/β ratio when evaluating isodoses of isoeffective radiation therapy treatment plans.Int J Radiat Oncol Biol Phys2013
24563726Prognostic value of <sup>18</sup>F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma.J Radiat Oncol2013
23474112Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes.Int J Radiat Oncol Biol Phys2013
23506832Cautious optimism for extreme dose escalation in prostate cancer.Eur Urol2013
23516584Detection of rapalog-mediated therapeutic response in renal cancer xenografts using ⁶⁴Cu-bevacizumab immunoPET.PLoS One2013
23348788Development and characterization of 89Zr-labeled panitumumab for immuno-positron emission tomographic imaging of the epidermal growth factor receptor.Mol Imaging2013
  • 1 - 50 of 61

Recommended Authors

Niluja Thiruthaneeswaran
The University of Sydney, Westmead Hospital
Career Start Year 2014
Number of shared co-authors 5
Soumyajit Roy
Rush University Medical Center
Career Start Year 2013
Number of shared co-authors 33
Andrew Warner
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 5
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 23
Darlene Veruttipong
Stanford University
Career Start Year 2012
Number of shared co-authors 10
Kiri A Sandler
Oregon Health and Science University
Career Start Year 2012
Number of shared co-authors 46
Matthew P Deek
Rutgers Robert Wood Johnson Medical School, Rutgers University
Career Start Year 2011
Number of shared co-authors 22
Alan Dal Pra
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 13
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 10
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 7
Bridget F Koontz
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 23
Himanshu Nagar
New York-Presbyterian Hospital, Weill Cornell Medical Center
Career Start Year 2005
Number of shared co-authors 14
Neil B Desai
University of Texas Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 29
Piet Ost
Ghent University, GZA Ziekenhuizen
Career Start Year 2002
Number of shared co-authors 34
Philip Wong
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 2
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 5
Andrew K Lee
Texas Center for Proton Therapy
Career Start Year 2001
Number of shared co-authors 2
Austin N Kirschner
Vanderbilt University Medical Center
Career Start Year 2000
Number of shared co-authors 0
Robert B Den
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 35
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Career Start Year 1996
Number of shared co-authors 9
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Career Start Year 1995
Number of shared co-authors 35
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 4
William Robert Lee
Duke University School of Medicine
Career Start Year 1993
Number of shared co-authors 35
Jeff M Michalski
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 60
Michael Milosevic
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1990
Number of shared co-authors 4
Seth A Rosenthal
Sutter Cancer Centers Radiation Oncology Services
Career Start Year 1987
Number of shared co-authors 43
Donald B Fuller
Division of Genesis Healthcare Partners Inc., CyberKnife Centers of San Diego Inc.
Career Start Year 1986
Number of shared co-authors 34
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 12
Andre Konski
Chester County Hospital
Career Start Year 1982
Number of shared co-authors 8
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1976
Number of shared co-authors 64

Collaborators

Mack Roach
University of California San Francisco
Co-authored papers 13
Amar U Kishan
University of California los angeles
Co-authored papers 10
Michael L Steinberg
University of California los angeles
Co-authored papers 9
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 6
Mitchell Kamrava
Cedars Sinai Medical Center
Co-authored papers 6
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Co-authored papers 5
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 4
Daniel J Krauss
William Beaumont School of Medicine
Co-authored papers 4
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 4
Brian J Davis
Mayo Clinic
Co-authored papers 4
Patrick A Kupelian
university of california los angeles Medical Center
Co-authored papers 4
Eric M Horwitz
Fox Chase Cancer Center
Co-authored papers 4
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 4
David Jeffrey Demanes
University of California los angeles
Co-authored papers 3
Richard G Stock
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Robert T Dess
University of Michigan ann arbor
Co-authored papers 3
David Shabsovich
university of california los angeles Medical Center
Co-authored papers 3
Jay P Ciezki
Cleveland Clinic
Co-authored papers 2
Ting Martin Ma
University of Washington
Co-authored papers 2
David Elashoff
David Geffen School of Medicine at University of California los angeles
Co-authored papers 2
Steve E Braunstein
University of California san francisco
Co-authored papers 2
Thomas A Hope
University of California san francisco
Co-authored papers 2
Constantine A Mantz
University of Chicago
Co-authored papers 2
Mark K Buyyounouski
Stanford University
Co-authored papers 2
Tahmineh Romero
David Geffen School of Medicine at university of california los angeles
Co-authored papers 2
Trude B Wedde
Oslo University Hospital
Co-authored papers 2
Lauren Boreta
Co-authored papers 2
Chandana A Reddy
Cleveland Clinic
Co-authored papers 2
Avinash Pilar
Princess Margaret Cancer Centre, University of Toronto
Co-authored papers 2
Michael Xiang
University of California los angeles
Co-authored papers 2
Release 1.2